The landscape of weight loss has shifted forever with the adoption of GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro. By 2026, these medications have become foundational tools in metabolic health. However, as millions have discovered, the medication is only half the equation. While these drugs effectively quiet "food noise," they change the fundamental rules of nutrition tracking.
In the pre-GLP-1 era, the struggle was restriction—fighting hunger to stay under a calorie ceiling. On GLP-1s, the goal often flips: the primary challenge is consumption. When appetite is suppressed, the risk shifts from overeating to under-nourishing. Specifically, you must hit a "protein floor" to prevent muscle wasting, stay hydrated to mitigate side effects, and ensure nutrient density on low volumes. In this guide, we evaluate the best trackers of 2026 for the GLP-1 user.
What a GLP-1 Tracker Actually Needs
A standard calorie counter that just warns you when you eat too much is no longer sufficient. A modern GLP-1-specific workflow requires:
1. Protein-Floor Tracking
The greatest risk of rapid loss on GLP-1s is losing lean muscle mass (sarcopenia). In the STEP 1 trial of semaglutide 2.4 mg, Wilding et al. (2021) reported roughly 15% total weight loss, with an exploratory body composition analysis estimating that around 40% of the lost mass was lean tissue. A tracker must allow you to set a non-negotiable daily protein target—a "floor" rather than a "ceiling." This helps bias the weight you lose toward fat, preserving your metabolism and strength.
2. Side-Effect Logging
Nausea, constipation, and fatigue are common companions to GLP-1 therapy. Tracking these alongside food helps identify triggers. By logging symptoms, you can provide your healthcare provider with high-resolution data to adjust your titration schedule.
3. Dose and Injection Tracking
GLP-1s are typically weekly injections. Keeping a log of when you took your dose and which site you used (thigh, abdomen) helps you correlate efficacy and side effects with your dose schedule. Many users feel different levels of suppression depending on the injection site.
4. Moving Average Weight Trends
GLP-1 loss is rarely linear. Water retention and medication cycles cause daily weight to swing. A tracker should emphasize a moving average to show the true trajectory of loss, reducing daily scale anxiety.
5. Hydration and Fiber
Slowed gastric emptying makes hydration and fiber intake paramount for digestive health. A tracker that prioritizes these metrics is essential for avoiding the GI issues that often derail medication progress.
The Seven Best Trackers for GLP-1 Users
1. Shotsy
Shotsy is the leader in the GLP-1-native category. Unlike legacy apps, Shotsy was designed specifically for this audience. Its interface centers on your injection cycle, showing your current dose and days since your last shot immediately.
Shotsy allows for detailed side-effect logging and correlates these symptoms with food intake. The premium tier includes AI-driven coaching focused on muscle preservation, warning you if you fail to hit the protein levels required to protect your lean mass. For a dedicated companion to your prescription, Shotsy is the gold standard of 2026.
2. Pep (GLP-1 Tracker)
Pep appeals to users wanting a modern, tech-forward feel. Its standout feature is advanced AI photo-scanning. Because GLP-1 users often eat smaller, frequent meals, Pep’s ability to identify protein-dense foods from a quick photo reduces logging friction significantly.
Pep also includes a robust fiber tracker and gamifies "protein floor" and hydration goals, making daily targets feel like achievements. If you value speed and visual logging within a GLP-1-specific framework, Pep is an excellent choice.
3. MyNetDiary GLP-1 Companion
MyNetDiary successfully pivoted by adding a dedicated GLP-1 module. This is ideal for those wanting a world-class, verified food database alongside specialized medication tracking.
The GLP-1 mode reorganizes the dashboard to prioritize protein, water, and side effects. It also includes a "Dose Tracker" to remind you of your injection day. The primary advantage is database depth; MyNetDiary is less likely to require manual entries for branded or restaurant foods.
4. MacroFactor
MacroFactor is a favorite for its adherence-neutral algorithm. It doesn't judge intake; it simply uses your data to calculate your expenditure (TDEE). This is uniquely suited for the metabolic changes of a GLP-1 journey.
MacroFactor’s "Protein Floor" setting is the best in the industry for preserving muscle. Weekly check-ins adjust your targets based on how your body actually responds. It is a fantastic tool for both the weight loss and maintenance phases, helping you understand your actual metabolic needs.
5. MyFitnessPal
MyFitnessPal remains a popular choice due to its massive database and user familiarity. While not GLP-1 specific, it can be effective if you manually override default goals to set high protein targets.
It lacks built-in side-effect or dose tracking, so you'll likely need a separate journal for medication specifics. However, for those with years of saved recipes and historical data, the "friction of switching" might outweigh the benefits of a specialized tool.
6. CalBurndown
CalBurndown is a neutral, engineering-led tracker that works well for GLP-1 users who find standard apps judgmental. Its core philosophy is the burndown chart, which shows your daily budget "burning down" toward zero.
Its hand-portion calculator is perfect for small-plate meals, and its focus on rucking math encourages the resistance-based movement necessary for bone and muscle health. The "burndown" view also helps ensure you prioritize protein even on days when appetite is low.
7. Cronometer
Cronometer is the undisputed king of micronutrient tracking, which is critical when GLP-1 medications drop your caloric intake. When volume is low, every calorie must be nutrient-dense.
Cronometer tracks over 80 nutrients, showing exactly where you might be deficient in B12, Iron, or Magnesium. While it doesn't have a dose tracker, its clinical accuracy ensures you aren't sacrificing health for weight loss. It is the best tool for those working closely with a dietitian.
Quick Comparison Table
| App | GLP-1-native? | Protein floor | Side-effect log | Dose reminder | Photo logging |
|---|---|---|---|---|---|
| Shotsy | Yes | Yes | Yes | Yes | No |
| Pep | Yes | Yes | Yes | Yes | Yes (AI) |
| MyNetDiary | Module | Yes | Yes | Yes | No |
| MacroFactor | No | Yes | No | No | No |
| MyFitnessPal | No | Manual | No | No | Premium |
| CalBurndown | No | Hand portion | No | No | Yes |
| Cronometer | No | Yes | No | No | Premium |
"Which One When" Rubric
- For a medication-native experience: Shotsy offers the most cohesive integration of drug and nutrition tracking.
- For the fastest logging: Pep uses AI vision to make logging small meals frictionless.
- For metabolic precision: MacroFactor provides the best math for preserving muscle.
- For preventing malnutrition: Cronometer tracks the micronutrients that matter most at low calorie levels.
- For engineering-led math: CalBurndown removes the stress of counting with a burndown chart and hand-calibration.
- For the path of least resistance: Simply enable the GLP-1 module in MyNetDiary.
The Bigger Picture: Beyond the Needle
By 2026, GLP-1 medications are recognized as a "metabolic bridge." Success depends on the habits built while "food noise" is silenced. Avoiding the "skinny fat" trap requires tracking protein and maintaining resistance training. Pick the tracker that reinforces these behaviors. The goal isn't just a smaller scale number; it's building a stronger, more resilient body.
For more on monitoring, see our post on what to track on GLP-1s.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications should only be taken under medical supervision. Consult your doctor before making significant changes to your nutrition or exercise.
Citations
- Wilding, J. P. H. et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine 384:989–1002.